Phenylpiracetam hydrazide

Phenylpiracetam hydrazide

Systematic (IUPAC) name
(R/S)-2-(2-Oxo-4-phenylpyrrolidin-1-yl)acetyl hydrazide
Clinical data
Trade names	Phenylpiracetam hydrazide
Pregnancy category	Unknown
Routes of administration	Oral
Legal status
Legal status	US: Not FDA approved; unscheduled
Identifiers
ATC code	none
Synonyms	Fonturacetam hydrazide
Chemical data
Formula	C12H15N3O2
Molar mass	218.3 g/mol
Chirality	Racemic mixture
SMILES O=C1CC(C2=CC=CC=C2)CN1CC(NN)=O
InChI InChI=1S/C12H14N2O2/c13-11(15)8-14-7-10(6-12(14)16)9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,13,15) Key:LYONXVJRBWWGQO-UHFFFAOYSA-N
(what is this?)  (verify)

Phenylpiracetam hydrazide, also known as fonturacetam hydrazide,^[1] is a designer drug that is a derivative of phenylpiracetam in which the amide group is replaced with a hydrazide group. It was first reported by a Russian research group in 1980 as part of a series of chemical compounds investigated as anticonvulsants.^[2] In an electroshock test it was found to have an ED₅₀ of 310 mg/kg.^[2]

See also

• Piracetam

References

1. "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended International Nonproprietary Names: List 63" (PDF). WHO Drug Information 24 (1): 56. 2010. Retrieved 26 November 2015.
2. Glozman, O. M.; Morozov, I. S.; Zhmurenko, L. A.; Zagorevskii, V. A. (1980). "Synthesis and anticonvulsive activity of 4-phenyl-2-pyrrolidinone-1-acetic acid amides". Khimiko-Farmatsevticheskii Zhurnal (in Russian) 14 (11): 43–48.